Weekly Docetaxel And Prednisolone Versus Prednisolone Alone In Androgen-Independent Prostate Cancer: A Randomized Phase II Study

Mon, 05 Mar 2007 02:00 PM EST

... UroToday.com- In 2004 two large randomized clinical trials demonstrated that docetaxel based chemotherapy improved survival in androgen-independent prostate cancer (AICAP). In combination with prednisone, patients had improved quality of life and this is now the standard therapy for AICAP. [click link for full article] ...